20-145564-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_030931.4(DEFB126):āc.208G>Cā(p.Val70Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000954 in 1,613,988 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_030931.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DEFB126 | NM_030931.4 | c.208G>C | p.Val70Leu | missense_variant | 2/2 | ENST00000382398.4 | NP_112193.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DEFB126 | ENST00000382398.4 | c.208G>C | p.Val70Leu | missense_variant | 2/2 | 1 | NM_030931.4 | ENSP00000371835 | P1 | |
DEFB126 | ENST00000542572.1 | n.128-15G>C | splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152128Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000159 AC: 40AN: 251324Hom.: 0 AF XY: 0.000221 AC XY: 30AN XY: 135824
GnomAD4 exome AF: 0.0000971 AC: 142AN: 1461742Hom.: 2 Cov.: 32 AF XY: 0.000136 AC XY: 99AN XY: 727180
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152246Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74434
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2021 | The c.208G>C (p.V70L) alteration is located in exon 2 (coding exon 2) of the DEFB126 gene. This alteration results from a G to C substitution at nucleotide position 208, causing the valine (V) at amino acid position 70 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at